National trends in prescription drug expenditures and projections for 2019.
Purpose Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2019 in nonfederal hospitals, clinics, and overall (all sectors). Methods Drug expenditure data through calendar year 2018 were obtained from the...
| Publicado en: | American Journal of Health-System Pharmacy Vol. 76; no. 15; pp. 1105 - 1122 |
|---|---|
| Autores principales: | , , , , , , , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
8/1/2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137628527&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 137628527 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10792082 1X3 jtl: American Journal of Health-System Pharmacy issn: 10792082 maglogo: N pubinfo: dt: 8/1/2019 vid: 76 iid: 15 pid: 622 pub: Oxford University Press / USA artinfo: ui: 137628527 137628527 137628527 10.1093/ajhp/zxz109 137628527 ppf: 1105 ppct: 17 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: National trends in prescription drug expenditures and projections for 2019. aug: au: Schumock, Glen T Stubbings, JoAnn Hoffman, James M Wiest, Michelle D Suda, Katie J Rim, Matthew H Tadrous, Mina Tichy, Eric M Cuellar, Sandra Clark, John S Matusiak, Linda M Hunkler, Robert J Vermeulen, Lee C affil: College of Pharmacy, University of Illinois at Chicago, Chicago, IL sug: subj: Drugs, Prescription Economics Economics, Pharmaceutical Trends Health Care Costs Human Drug Utilization Evaluation Drug Approval Patents Hospitals, Federal Quantitative Studies Data Analysis Descriptive Statistics ab: Purpose Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2019 in nonfederal hospitals, clinics, and overall (all sectors). Methods Drug expenditure data through calendar year 2018 were obtained from the IQVIA National Sales Perspectives database and analyzed. New drug approvals, patent expirations, and other factors that may influence drug spending in hospitals and clinics in 2019 were also reviewed. Expenditure projections for 2019 for nonfederal hospitals, clinics, and overall (all sectors) were made through a combination of quantitative analyses and expert opinion. Results U.S. prescription sales in calendar year 2018 totaled $476.2 billion, a 5.5% increase from 2017 spending. The top 3 drugs by expenditures were adalimumab ($19.1 billion), insulin glargine ($9.3 billion), and etanercept ($8.0 billion). Prescription expenditures in nonfederal hospitals totaled $35.8 billion, a 4.8% increase from 2017. Expenditures in clinics in 2018 increased by 13.0% to $80.5 billion. The increase in spending in nonfederal hospitals was largely driven by new products and increased utilization of existing products. The list of the top 25 drugs by expenditures in nonfederal hospitals and clinics was dominated by specialty drugs. Conclusion We predict continued moderate growth of 4–6% in overall drug expenditures (across the entire U.S. market). We expect the clinic sector to continue to experience high (11–13%) growth in drug spending in 2019. Finally, for nonfederal hospitals we anticipate growth in the range of 3–5%. These estimates are at the national level. Health-system pharmacy leaders should carefully examine local drug utilization patterns to determine their own organization's anticipated spending in 2019. pubtype: Academic Journal doctype: research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|